Unnecessary peripheral intravenous catheterisation on an acute medical admissions unit: A preliminary study

European Journal of Internal Medicine

Volumn 13, Issue 6, 2002, Pages 380-384

  Barlow, G D ^a   Palniappan, S ^a   Mukherjee, R ^a   Jones, M C ^a   Nathwani, D ^a  

^a NHS TAYSIDE   (United Kingdom)

Author keywords

Acute medical admissions ward; Peripheral intravenous cannula; Peripheral intravenous catheter

Indexed keywords

ACETYLCYSTEINE; ANALGESIC AGENT; ANTIEMETIC AGENT; ANTIINFECTIVE AGENT; CARDIAC AGENT; INFUSION FLUID; INOTROPIC AGENT; INSULIN; LOW MOLECULAR WEIGHT HEPARIN; STEROID;

ACUTE DISEASE; ARTICLE; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; COST BENEFIT ANALYSIS; FIRST AID; HOSPITAL ADMISSION; HUMAN; LUNG DISEASE; MAJOR CLINICAL STUDY; MEDICAL PRACTICE; PROSPECTIVE STUDY; UNITED KINGDOM; VEIN CATHETERIZATION; WARD;

EID: 0036753711     PISSN: 09536205     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0953-6205(02)00126-7     Document Type: Article

References (16)

1. Curran E.T., Coia J.E., Gilmour H., McNamee S., Hood J. Multi-centre research surveillance project to reduce infections/phlebitis associated with peripheral catheters. J Hosp Infect. 46:2000;194-202.
2. Tager I.R., Ginsberg M.B., Ellis S.E., et al. An epidemiologic study of the risks associated with peripheral intravenous catheters. Am J Epidemiol. 118:1983;839-851.
3. Soifer N.E., Borzak S., Edlin B.R., Weinstein R.A. Prevention of peripheral venous catheter complications with an intravenous therapy team. A randomised controlled trial. Arch Intern Med. 158:1998;473-477.
4. Wischnewski N., Kampf G., Gastmeier P., et al. Prevalence of primary bloodstream infections in representative German hospitals and their association with central and peripheral catheters. Zentralblatt fur Bakteriologie. 287:1998;93-103.
5. Nystrom B., Larsen S.O., Dankert J., et al. Bacteraemia in surgical patients with intravenous devices: a European multicentre incidence study. The European Working Party on Control of Hospital Infections. J Hosp Infect. 4:1983;338-349.
6. Mylotte J.M., McDermott C. Staphylococcus aureus bacteremia caused by infected intravenous catheters. Am J Infect Control. 15:1987;1-6.
7. Vincent C., Neale G., Woloshynowych M. Adverse events in British hospitals: preliminary retrospective record review. Br Med J. 322:2001;517-519.
8. Masterton R.G., Teare E.L. Clinical governance and infection control in the United Kingdom. J Hosp Infect. 47:2001;25-31.
9. Jones G.R., Lowes J.A. The systemic inflammatory response syndrome as a predictor of bacteraemia and outcome from sepsis. Q J Med. 89:1996;515-522.
10. Hope R.A., Longmore J.M., Hodgetts T.J., Ramrakha P.S. Oxford handbook of clinical medicine. 3rd Ed: 1993;Oxford University Press, Oxford.
11. Meier P.A., Fredrickson M., Catney M., Nettleman M.D. Impact of a dedicated intravenous therapy team on nosocomial bloodstream infection rates. Am J Infect Control. 26:1998;388-392.
12. Lundgren A., Jorfeldt L., Ek A.C. The care and handling of peripheral intravenous cannulae on 60 surgery and internal medicine patients: an observation study. J Adv Nurs. 18:1993;963-971.
13. Parras F., Ena J., Bouza E., et al. Impact of an educational program for the prevention of colonization of intravascular catheters. Infect Control Hosp Epidemiol. 15:1994;239-242.
14. Lundgren A., Wahren L.K. Effect of education on evidence-based care and handling of peripheral intravenous lines. J Clin Nurs. 8:1999;577-585.
15. Cooper N. Patient at risk. Clin Med J R Coll Phys Lond. 1:2001;309-311.
16. Tomford J.W., Hershey C.O., McLaren P., et al. Intravenous therapy team and peripheral venous catheter-associated complications. A prospective controlled study. Arch Intern Med. 144:1984;1191-1194.